
Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy
Keywords: CML, chronic myeloid leukemia; KD, kinase domain; TKI, tyrosine kinase inhibitors; HD, healthy donors; OR, optimal responders; OR-IN, optimal responders to TKI treated with imatinib or nilotinib; OR-D, optimal responders to TKI treated with dasatinib; CP-